Genolution Inc. (KOSDAQ:225220)
1,484.00
+6.00 (0.41%)
At close: Oct 1, 2026
Genolution Market Cap
Genolution has a market cap or net worth of 26.81 billion as of October 1, 2026. Its market cap has decreased by -35.05% in one year.
Market Cap
26.81B
Enterprise Value
23.06B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,484.00
ChartMarket Cap Chart
Since April 5, 2017, Genolution's market cap has increased from 16.87B to 26.81B, an increase of 58.95%. That is a compound annual growth rate of 5.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 26.81B | -21.85% |
| Dec 30, 2025 | 34.31B | -14.60% |
| Dec 30, 2024 | 40.17B | -45.41% |
| Dec 28, 2023 | 73.59B | -15.58% |
| Dec 29, 2022 | 87.18B | -42.33% |
| Dec 30, 2021 | 151.16B | 15.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Synergy Innovation | 140.00B |
| Celemics | 114.95B |
| RecensMedical | 96.80B |
| Corentec | 63.48B |
| DENTIS CO.,Ltd | 41.34B |
| Finemedix | 34.21B |
| Sanigen Co. | 29.75B |
| TASCOM | 22.85B |